$HQL insiders have traded $HQL stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales. Here’s a ...

abrdn Life Sciences Investors Fund maintains a buy rating, offering a compelling 11.6% yield and trading at a 9.58% NAV discount. HQL’s income-focused strategy relies on net realized gains, supporting ...

Tekla Life Sciences Investors is a closed-ended equity fund that primarily invests in the life sciences sector, with a heavy focus on biotech and pharmaceuticals. The fund's dividend history has been ...

目前没有该公司的股息历史记录信息。 这可能表明该公司从未发放过股息或 股息待定。 “股息历史记录”页面是一个单独页面，可查看所有汇总的股息支付信息。请访问我们的股息日历：我们的合作伙伴 Zacks Investment Research 提供了下个月的除息日期。